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The surveillance of Legionnaires’ disease (LD) in Europe 
is carried out by the European Legionnaires’ Disease 
Surveillance Network (ELDSNet) and coordinated 
by the European Centre for Disease Prevention and 
Control (ECDC). All cases reported in 2009 and 2010 
and meeting the European case definition were elec-
tronically transmitted to The European Surveillance 
System (TESSy) database. A total of 5,551 and 6,305 
cases were reported by 29 European countries in 2009 
and 2010, respectively. The age-standardised rate of 
all cases was 1.20 per 100,000 inhabitants in 2010, 
12% higher than in 2009, which was consistent with 
the increasing trend observed since 2005. Most of 
this increase consisted of community-acquired cases 
reported by France, Germany and the Netherlands with 
dates of onset in August–September. The exception-
ally hot summer of 2010 in some parts of Europe may 
have played a role in this increase.
Background
Legionnaires’ disease (LD) is the severe and sometimes 
fatal form of an infection with Legionella spp. LD is 
classically described as a severe pneumonia that may 
be accompanied by systemic symptoms such as fever, 
diarrhoea, myalgia, impaired renal and liver functions, 
and delirium. These gram-negative bacteria are found 
in freshwater environments worldwide and tend to 
contaminate man-made water systems [1]. Humans are 
infected by inhalation of aerosols containing legionel-
lae. One species of Legionella, L. pneumophila is the 
aetiological agent of approximately 90% of all LD 
cases. Among the 16 identified serogroups of L. pneu-
mophila, L. pneumophila serogroup 1 is the most com-
monly involved (approximately 85% of all LD cases) 
[1,2]. The surveillance of LD at European level started 
in 1996 and LD surveillance reports were published 
every other year from 2000 onwards [3-6]. Since 2010, 
the surveillance of LD in Europe has been carried out 
by the European Legionnaires’ Disease Surveillance 
Network (ELDSNet) and coordinated by the European 
Centre for Disease Prevention and Control (ECDC) in 
Stockholm, Sweden. 
Following a period of steady increase of annually 
reported cases after implementing surveillance at 
European level, the number of reported cases of LD 
seemed to reach a plateau of between 5,500 and 6,000 
cases from 2005 to 2009 [7]. Here we present cases 
reported in the European Union (EU) as well as Iceland 
and Norway for 2009 and 2010, with a focus on the 
increase observed in 2010. To put this increase into 
perspective, the trend observed since 2005 was also 
analysed.
Methods
ELDSNet comprises all 27 EU Member States, Iceland 
and Norway. One of the key objectives of the network 
is the annual collection, analysis, interpretation and 
communicating of surveillance data on all LD cases 
reported at national level during the previous year. Each 
year, nominated ELDSNet members in each of the par-
ticipating countries are asked to electronically transmit 
their data to The European Surveillance System (TESSy) 
database hosted by ECDC. In 2010, when the first data 
call was made, ELDSNet members were also asked to 
upload respective historical data since 2005. All cases 
reported in 2009 and 2010, meeting the EU case defini-
tion of confirmed and probable cases, were included in 
the main analysis [8]. Cases reported since 2005 were 
included in the trend analysis. 
 Cases were to be reported as part of a cluster if they 
had been exposed to the same source as at least one 
other case with dates of disease onset no more than two 
years apart. Information retrieved from TESSy included 
age, sex, date of disease onset, probable setting of 
infection, laboratory methods used for diagnosis, and 
clinical outcome. Possible settings of infection were, 
among others, community-acquired, travel-related and 
healthcare-associated. Population denominator data 
for calculating rates were obtained from the Statistical 
Office of the European Union (Eurostat) [9]. 
Continuous variables were compared across strata by 
the Mann-Whitney U test. Categorical variables were 
compared using the Chi-square or Fisher exact tests. 
Age-standardised rates (ASR) were calculated using 
the direct method and the average age structure of the 
EU population for the period 2000 to 2010. 
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To analyse the trend since 2005, we performed a time 
series analysis over the 2005 to 2010 period for the 
five largest reporting countries (France, Germany, Italy, 
Spain and the United Kingdom). The analysis was lim-
ited to these countries because they provided data for 
the whole period and accounted for a substantial pro-
portion of all cases reported. Weeks of disease onset 
were analysed for trend (linear regression). Where 
the information on the exact day of disease onset 
was not available, it was assumed to be the first day 
of the month. It was assumed that the population in 
these countries remained stable over the study period. 
Statistical analyses were performed using STATA ver-
sion 11.2 (Statacorp, College Station, TX, USA).
Results
Case classification, notification rate 
and geographical distribution
Of the 11,856 cases notified over the 2009–10 period, 
92% (n=10,960) were confirmed cases, with simi-
lar distribution in both years. Eight hundred and 
Table 1
Number, crude and age standardised (ASR) rates of reported confirmed and probable cases of Legionnaires’ disease by 
reporting country, European Union, Iceland and Norway, 2009-2010
Reporting country 
2009 2010
Ratesa per  100 000 inhabitants Ratesb per 100 000 inhabitants
Cases Crude rate ASR Cases Crude rate ASR
Austria 92 1.10 1.07 80 0.96 0.91
Belgium 80 0.70 0.68 89 0.82 0.79
Bulgaria 3 0.04 0.04 1 0.01 0.01
Cyprus 3 0.38 0.45 2 0.25 0.32
Czech Republic 18 0.17 0.18 38 0.36 0.35
Denmark 123 2.23 2.24 133 2.40 2.37
Estonia 6 0.45 0.44 0 0.00 0.00
Finland 22 0.41 0.40 24 0.45 0.42
France 1,206 1.87 1.88 1,540 2.38 2.37
Germany 503 0.61 0.55 688 0.84 0.75
Greece 15 0.13 0.13 9 0.08 0.07
Hungary 65 0.65 0.63 60 0.60 0.59
Ireland 7 0.16 0.19 11 0.25 0.31
Italy 1,207 2.01 1.80 1,238 2.05 1.83
Latvia 3 0.13 0.12 6 0.27 0.26
Lithuania 0 0.00 0.00 1 0.03 0.03
Luxembourg 5 1.01 1.08 10 1.99 2.02
Malta 5 1.21 1.25 6 1.45 1.33
the Netherlands 251 1.52 1.53 466 2.81 2.79
Poland 10 0.03 0.02 36 0.09 0.10
Portugal 96 0.89 0.86 128 1.19 1.15
Romania 3 0.01 0.01 1 0.00 0.00
Slovakia 2 0.04 0.04 4 0.07 0.07
Slovenia 66 3.25 3.11 58 2.83 2.68
Spain 1,231 2.68 2.66 1,150 2.48 2.45
Sweden 114 1.23 1.18 100 1.07 1.01
United Kingdom 374 0.61 0.61 376 0.61 0.61
EU 27 5,510 1.10 1.07 6,255 1.25 1.20
Iceland 7 2.20 2.83 2 0.63 0.87
Norway 34 0.70 0.73 48 0.99 1.02
Total 5,551 1.10 1.07 6,305 1.24 1.20
ASR: age standardised rates; EU: European Union. 
a Information on age available for 5,544 cases in 2009.
b Information on age available for 6,293 cases in 2010.
3www.eurosurveillance.org
ninety-six were probable cases with 24 defined on 
epidemiological grounds only. The ASR of confirmed 
and probable cases was 1.20 per 100,000 inhabitants 
in 2010, 12% higher than in 2009 (1.07 per 100,000) 
(Table 1). The ASR greatly varied across countries and 
was highest in Slovenia in 2009 (3.11 per 100,000) and 
in the Netherlands in 2010 (2.79 per 100,000). The six 
countries reporting the highest number of cases i.e. 
France, Germany, Italy, Netherlands, Spain and the 
United Kingdom, accounted for 86% (n=4,772) and 
87% (n=5,458) of all cases reported in 2009 and 2010, 
respectively. The ASR increase was especially high in 
the Netherlands (+83%), Germany (+37%) and France 
(+26%). 
Probable setting of infection
For 10,582 cases reported in 2009 and 2010, the prob-
able setting of infection was known. Of these, 71% 
(n=7,397) were community-acquired, 20% (n=2,187) 
travel-associated, 8% (n=893) healthcare-related and 
1% (n=103) were associated with other settings (Table 
2). The distribution of probable settings of infection 
was similar in both years. 
Clusters
Of 7,872 cases with known cluster status, 8% (n=662) 
were reported as part of a cluster. This proportion was 
higher in travel-associated cases 20% (284 of 1,399) 
and lower in community-acquired cases with 5% (259 
of 5,015) reported as part of a cluster. This proportion 
was similar in both years.
Seasonality
Information for date of disease onset was available 
for 11,305 cases reported in 2009–10; 59% (n=6,702) 
fell ill between June and October (warm season). This 
proportion was identical in both years and the same 
seasonal pattern was observed as in previous years 
(Figure 1). 
Age and sex
Information on age was available for 11,836 cases, of 
which 43% (n=5,100) were 65 years old or older. Of 
the 11,849 cases reported with known sex in 2009–10, 
73% (n=8,611) were male. Sex ratio was similar in both 
years. The notification rate increased with age in both 
sexes and was below 0.1 per 100,000 inhabitants in 
those under 24 years of age, 0.5 in 25-44 year-olds, 1.9 
in 45-64 year-olds and 2.9 in those 65 years of age and 
older. 
Laboratory tests and pathogens
A total of 11,832 confirmed and probable cases were 
ascertained by 11,976 laboratory tests. Of these 
tests, 82% (n=9,780) were urinary antigen tests, 10% 
(n=1,185) were cultures, 5% (n=571) single high titre 
in specific serum antibody, 2% (n=303) polymerase 
chain reaction (PCR), 1% (n=141) fourfold titre rise and 
only 10 tests performed were direct immunofluores-
cence. The distribution of the tests was similar in both 
years. Of the 1,166 culture-confirmed cases for which 
the pathogen was reported, 85% (n=991) were due to 
L. pneumophila serogroup 1 and this proportion was 
similar in both years.
Outcome
The clinical outcome was known for 8,107 cases, 852 
of them died, yielding a case fatality rate (CFR) of 11% 
which was similar in both years. 
Increase of number of cases reported in 
2010 compared to the 2008–09 average
Of the 995 excess cases reported in 2010 compared 
with the 2008–09 average, 67% (n=663) were reported 
by France, Germany and the Netherlands. Analysis 
by month of disease onset showed that the largest 
increases were observed in January (+52%, 148 cases) 
and August (+50%, 325 cases). Of the 775 excess cases 
reported in 2010 with known setting of infection, 89% 
(n=686) were community-acquired. When restricting 
the analysis to community-acquired cases reported 
by France, Germany and the Netherlands, the increase 
was concentrated on January, August and September 
with a two-fold increase compared to the 2008–09 
average in these respective months (Figure 2). 
Table 2
Distribution of reported cases of Legionnaires’ disease by setting, European Union, Iceland and Norway, 2009-2010
Setting 2009Cases (%)
2010
Cases (%)
2009-2010 difference
(%)
Community-acquired 3,398 (68) 3,999 (71) +18
Travel-associated 1,055 (21) 1,132 (20) +7
Travel abroad 523(10) 560 (10) +7
Domestic travel 532 (11) 572 (10) +8
Healthcare-associated 471 (9) 424 (8) -10
Other settings 44 (1) 59 (1) +34
Total 4,968 (100) 5,614 (100) +13
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Figure 1
Reported cases of Legionnaires’ disease by month of onset, European Union, Iceland and Norway, 2010 and 2008-2009 
average (n=16,549)
0
250
500
750
1,000
1,250
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2010
2008-2009 average
Nu
m
be
r o
f c
as
es
Month
Figure 2
Reported cases of community-acquired Legionnaires’ disease in France, Germany and the Netherlands by month of disease 
onset, 2010 and 2008-2009 average (n=3,648)
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The increase observed in January was only seen in 
France. Community-acquired cases reported by France, 
Germany and the Netherlands did not differ from 
other cases in terms of age or sex distribution. Cases 
reported with a date of onset in August and September 
had a lower CFR as compared to the rest of the year (9 
vs. 11%, p<0.01) which again was similar in both years.
Time series analysis of Legionnaires’ disease 
cases reported by France, Germany, Italy, 
Spain and the United-Kingdom, 2005–2010
 Of the 32,493 cases reported during the 2005 to 2010 
period, 86% (n=28,194) were reported by the five coun-
tries reporting the largest number of cases, namely 
France (n=8,388), Germany (n=3,164), Italy (n=6,401), 
Spain (n=7,515) and the United Kingdom (n=2,636). Of 
these, 99% (n=27,707) had a known date (or month) 
of disease onset. Overall, a slightly increasing linear 
trend in the number of reported cases was observed 
over the period (p<0.05) (Figure 3). 
Discussion
Following several years of relatively stable LD notifi-
cation rates from 2007 to 2009, we observed a 12% 
increase of the ASR in the EU countries, Iceland and 
Norway in 2010 compared with 2009. It is notewor-
thy that this increase mainly occurred in community-
acquired cases reported by France, Germany and the 
Netherlands with dates of disease onset in August and 
September while Italy and Spain continued to report a 
high number of cases but similar to what was observed 
in previous years. It can probably partly be explained 
by the increasing trend in the reported number of cases 
observed since 2005. It is unlikely a random variation 
and an artefact due to reporting issues can be ruled 
out, as cases represent true cases checked by the 
countries participating in the network. None of them 
reported a change in their surveillance system and the 
increase was mainly concentrated on two months and 
three countries. 
Most of the excess cases were sporadic cases or part of 
small clusters which went unnoticed. To our knowledge, 
the largest outbreak reported in 2009–10 involved a 
Slovenian nursing home in August 2010 [10]. National 
reports from France and the Netherlands mentioned 
increasing numbers of LD cases during summer 2010 
but causes remained unclear and were to be further 
investigated [11,12] The Dutch notification rate in 2010 
was the highest ever recorded since introducing LD 
surveillance in the Netherlands in 1988 [11]. However, 
since the Netherlands reported fewer cases in 2009 as 
compared to previous years, the observed increase of 
the ASR (+82%) should be interpreted with care. If we 
compared 2010 with 2008 ASR, the increase would be 
around 40%, more in line with the increase observed 
in France and Germany. Of note, the 2010 increase in 
France was more pronounced in eastern regions [12] as 
previously documented for the period 2002 to 2008 as 
well [13]. 
The Dutch region with the highest notification rate was 
located in the northeast of the country [11]. Having rela-
tively confined regions affected at the same time would 
suggest a global temporary environmental change such 
as a heat wave, in conjunction with heavy rains. This 
Figure 3
Reported cases of Legionnaires’ disease by week of onset, linear trend and 52 weeks moving average, France, Germany, Italy, 
Spain and the United Kingdom, 2005-2010 (n=27,707)
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would be supported by previous findings suggesting 
an impact of climate on the number of cases reported 
[14-17]. In the absence of any obvious explanatory fac-
tor, the summer peak in reported cases may have been 
related to the exceptionally warm summer observed 
in 2010 Europe [18]. Unfortunately, since places of 
residence were not collected at the EU level, it was not 
possible to introduce environmental variables such 
as temperature or precipitation with conditions likely 
to vary substantially from one region to another for a 
given country. Interestingly, the cases reported during 
this peak did not differ from other cases in terms of 
age and sex or outcome. 
The 2009-10 data also confirm previous findings 
regarding the wide range of LD notification rates in 
Europe. When restricting the calculation of ASR to 
community-acquired cases, rates observed can be 
explained neither by environmental conditions nor 
by national legislation regarding potential sources of 
exposure such as wet cooling systems [19]. Thus, the 
number of cases reported in several European coun-
tries, from Germany to Greece, remains far below what 
would be expected. The reservoir of unascertained 
cases would probably be found in community-acquired 
cases in countries that have so far been poorly diag-
nosed and reported. We expect these countries to drive 
any future increase in the number of cases reported.
Conclusion
LD is an infectious disease leading to the death of 
around 500 EU citizens every year. In 2010, an as yet 
unexplained increase of cases of community-acquired 
LD cases was observed mainly in France, Germany and 
the Netherlands in August and September. Although 
consistent with the overall increasing trend observed 
since 2005, it is striking that this increase was concen-
trated over a short period of time and in a relatively 
restricted geographical area. This increase in 2010 
indicates an impact on the disease incidence in rela-
tion with probable weather conditions or other envi-
ronmental factors. A possible explanation would be 
the unusually hot summer 2010. With global warming 
and an increasing risk of extreme weather in the near 
future, such situations should be further investigated 
to target campaigns of information and control meas-
ures. More research would be needed to identify the 
factors associated with sporadic community-acquired 
cases. The collection of geographical information at 
sub-national level should help validate the impact of 
climate on LD incidence at the European level. Last, 
reasons for the low notification rates observed in east-
ern and south-eastern European countries need to be 
elucidated by targeted studies aimed at identifying the 
causes of under-ascertainment.
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